December 24, 2010 -- The Tianjin-Israel Biomedical Equity Investment Fund raised $100 million with a goal of sponsoring the transfer of Israeli biomedical projects to Tianjin. The fund is co-managed by Tianjin Venture Capital Management Co., Ltd. and Israel Infinity Group. It will invest in biomedical ventures, which will also include medical equipment, health care and innovation in medical models. More details....
